Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization-Reference-Cited by-同舟云学术

Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization

Published:2015-06 Issue:6 Volume:122 Page:1220-1227
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Ikuno Yasushi,Ohno-Matsui Kyoko,Wong Tien Yin,Korobelnik Jean-Francois,Vitti Robert,Li Tummy,Stemper Brigitte,Asmus Friedrich,Zeitz Oliver,Ishibashi Tatsuro

Publisher

Elsevier BV

Subject

Ophthalmology

Reference27 articles.

1. Update on the pathology of pathologic myopia;Rashid,2014

2. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review;Wong;Am J Ophthalmol,2014

3. Prevalence and risk factors for myopic retinopathy in a Japanese population: the Hisayama Study;Asakuma;Ophthalmology,2012

4. Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study;Iwase;Ophthalmology,2006

5. Prevalence of myopia in adults: implications for refractive surgeons;McCarty;J Refract Surg,1997

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macular neovascularization;Survey of Ophthalmology;2024-08

2. Risk Factors for Aggravation of Myopic Retinoschisis after Intravitreal Bevacizumab Injection in Myopic Choroidal Neovascularization;Journal of the Korean Ophthalmological Society;2024-05-15

3. The carbon footprint and wastage of intravitreal injections;Journal Français d'Ophtalmologie;2024-04

4. Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone to recur after anti-VEGF therapy;Eye and Vision;2024-02-07

5. MACULAR CHORIORETINAL ATROPHY AND VISUAL OUTCOMES IN RANIBIZUMAB- OR AFLIBERCEPT-TREATED MYOPIC CHOROIDAL NEOVASCULARIZATION;Retina;2024-01